Swiss National Bank’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-69,900
| Closed | -$6.78M | – | 2576 |
|
|
2019
Q3 | $6.78M | Hold |
69,900
| – | – | 0.01% | 932 |
|
|
2019
Q2 | $7.16M | Buy |
69,900
+8,000
| +13% | +$819K | 0.01% | 913 |
|
|
2019
Q1 | $7.05M | Buy |
61,900
+2,100
| +4% | +$239K | 0.01% | 894 |
|
|
2018
Q4 | $2.34M | Buy |
59,800
+1,500
| +3% | +$58.7K | ﹤0.01% | 1460 |
|
|
2018
Q3 | $3.18M | Hold |
58,300
| – | – | ﹤0.01% | 1418 |
|
|
2018
Q2 | $4.83M | Buy |
58,300
+3,600
| +7% | +$298K | 0.01% | 1128 |
|
|
2018
Q1 | $3.64M | Buy |
54,700
+3,300
| +6% | +$220K | ﹤0.01% | 1248 |
|
|
2017
Q4 | $2.64M | Hold |
51,400
| – | – | ﹤0.01% | 1466 |
|
|
2017
Q3 | $4.58M | Buy |
51,400
+12,200
| +31% | +$1.09M | 0.01% | 1070 |
|
|
2017
Q2 | $2.34M | Buy |
39,200
+1,500
| +4% | +$89.6K | ﹤0.01% | 1486 |
|
|
2017
Q1 | $2.01M | Hold |
37,700
| – | – | ﹤0.01% | 1564 |
|
|
2016
Q4 | $1.88M | Buy |
37,700
+1,200
| +3% | +$59.9K | ﹤0.01% | 1594 |
|
|
2016
Q3 | $2.19M | Sell |
36,500
-100
| -0.3% | -$6.01K | ﹤0.01% | 1441 |
|
|
2016
Q2 | $1.87M | Buy |
36,600
+6,900
| +23% | +$353K | ﹤0.01% | 1552 |
|
|
2016
Q1 | $846K | Buy |
29,700
+8,500
| +40% | +$242K | ﹤0.01% | 2008 |
|
|
2015
Q4 | $961K | Buy |
21,200
+10,200
| +93% | +$462K | ﹤0.01% | 1848 |
|
|
2015
Q3 | $459K | Buy |
11,000
+1,400
| +15% | +$58.4K | ﹤0.01% | 2215 |
|
|
2015
Q2 | $579K | Buy |
+9,600
| New | +$579K | ﹤0.01% | 2155 |
|